Atara Biotherapeutics Files 8-K

Ticker: ATRA · Form: 8-K · Filed: May 6, 2025 · CIK: 1604464

Atara Biotherapeutics, INC. 8-K Filing Summary
FieldDetail
CompanyAtara Biotherapeutics, INC. (ATRA)
Form Type8-K
Filed DateMay 6, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: 8-K, regulatory-filing, financial-statements

Related Tickers: ATRA

TL;DR

ATRA filed an 8-K, likely financial/event updates. Keep an eye out.

AI Summary

On May 5, 2025, Atara Biotherapeutics, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicating updates or disclosures related to the company's financial status and operational events. No specific financial figures or new material events were detailed in the provided excerpt.

Why It Matters

This filing signals that Atara Biotherapeutics is providing updates to the SEC, which could contain important information for investors regarding the company's financial health or significant operational developments.

Risk Assessment

Risk Level: low — The filing is a standard 8-K for reporting events and financial statements, with no immediate indication of negative news or significant risk in the provided text.

Key Players & Entities

FAQ

What specific "Other Events" are being reported by Atara Biotherapeutics in this 8-K filing?

The provided excerpt does not detail the specific "Other Events" being reported; it only lists the item category.

What is the date of the earliest event reported in this 8-K filing?

The date of the earliest event reported is May 5, 2025.

What is the Commission File Number for Atara Biotherapeutics, Inc.?

The Commission File Number for Atara Biotherapeutics, Inc. is 001-36548.

Where are Atara Biotherapeutics, Inc.'s principal executive offices located?

Atara Biotherapeutics, Inc.'s principal executive offices are located at 1280 Rancho Conejo Blvd, Thousand Oaks, California, 91320.

What is the IRS Employer Identification Number for Atara Biotherapeutics, Inc.?

The IRS Employer Identification Number for Atara Biotherapeutics, Inc. is 46-0920988.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on May 6, 2025 regarding Atara Biotherapeutics, Inc. (ATRA).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing